Brain Cancer Trial, Recruiting NCT06203496 Sponsor: University Hospital, Caen Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT06203496
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are adults (18 years of age or older)
  • People diagnosed with a grade 4 diffuse glioma (a specific type of aggressive brain tumour)
  • People who had their brain surgery performed at the neurosurgery department of Caen University Hospital
  • People who are enrolled in a French social security scheme (public health insurance)
  • People who are being monitored and followed up at Caen University Hospital
  • People who have not objected to taking part in the study

Who may not be able to join:

  • People who only had a biopsy (a small tissue sample taken) rather than surgical removal of the tumour
  • People diagnosed with a grade 1, 2, or 3 glioma (lower-grade brain tumours), rather than grade 4
  • People whose brain tumour is of a type other than diffuse glioma, including certain mixed tumour types (confirm with trial site)
  • People who are under 18 years of age
  • People who are not enrolled in a French social security scheme
  • Minors who are under legal guardianship or a protection order
  • People who have expressed opposition to participating in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Caen
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Recurrence of glioma on MRI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov